UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation

Clinical gastroenterology and hepatology, 2017-05, Vol.15 (5), p.682-690

2017

Volltextzugriff (PDF)

Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran

Digestive diseases and sciences, 2018-07, Vol.63 (7), p.1878-1889

2018

Volltextzugriff (PDF)

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

European heart journal, 2002-12, Vol.23 (23), p.1809-1840

2002

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

The Lancet (British edition), 2002-01, Vol.359 (9302), p.189-198

2002

Volltextzugriff (PDF)

Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome

Thrombosis and haemostasis, 2010-11, Vol.104 (5), p.976

2010

Volltextzugriff (PDF)

Mo1999 How Often Does Major Gastrointestinal Bleeding in Patients Receiving Warfarin or Dabigatran Uncover Cancer? The U.S. Experience From the RELY Trial

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-764-S-764

2015

Volltextzugriff (PDF)

Recommendations for the structure, organization, and operation of intensive cardiac care units

European heart journal, 2005-08, Vol.26 (16), p.1676-1682

2005

Volltextzugriff (PDF)

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

European heart journal, 2018-11, Vol.39 (42), p.3766-3776

2018

Volltextzugriff (PDF)

Cardiovascular disease on a global scale: defining the path forward for research and practice

European heart journal, 2007-11, Vol.28 (21), p.2678-2684

2007

Volltextzugriff (PDF)

Third Universal Definition of Myocardial Infarction

Circulation, 2012-10, Vol.126 (16), p.2020-2035

2012

Volltextzugriff (PDF)

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

European heart journal, 2006-12, Vol.27 (24), p.2956-2961

2006

Volltextzugriff (PDF)

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

Heart (British Cardiac Society), 2007-04, Vol.93 (4), p.450-455

2007

Volltextzugriff (PDF)

Abstract 10162: NT-proBNP is Associated with Stroke, Heart Failure Hospitalizations, and Death in Patients with Atrial Fibrillation Without Oral Anticoagulation Regardless of Heart Rhythm

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Abstract 12361: Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AF

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Universal definition of myocardial infarction

Circulation, 2007-11, Vol.116 (22), p.2634-2653

2007

Volltextzugriff (PDF)

Abstract 9290: Relationship Between Body Weight and Pharmacokinetics of Apixaban in Patients With Atrial Fibrillation: Insights from the ARISTOTLE Trial

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

The American heart journal, 2021-03, Vol.233 (233), p.48-58

2021

Volltextzugriff (PDF)

Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Third universal definition of myocardial infarction

Nature reviews cardiology, 2012-11, Vol.9 (11), p.620

2012

Volltextzugriff (PDF)

Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy

European heart journal, 2015, Vol.36 (Suppl. 1), p.1041

2015

Volltextzugriff (PDF)

High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin

European heart journal, 2012, Vol.33 (Suppl 1), p.53

2012

Volltextzugriff (PDF)

NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin

European heart journal, 2012, Vol.33 (Suppl 1), p.51

2012

Volltextzugriff (PDF)

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization

Journal of the American College of Cardiology, 1991-12, Vol.18 (7), p.1587-1593

Wallentin, Lars C.

1991

Volltextzugriff (PDF)

Abstract 13812: A Functional Polymorphism in Matriptase-2, Rs855791, Modifies Interleukin-6 Mediated Cardiovascular Risk

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A13812-A13812

2019

Volltextzugriff (PDF)

Abstract 14397: Novel CYP2C19 Genetic Variants Associated With Stent Thrombosis - A Next Generation Sequencing Study

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A14397-A14397

2019

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(307)

Publikationsform

Artikel
(328)
Tagungsberichte
(3)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(213)
Humans
(198)
Cardiovascular System & Cardiology
(166)
Cardiac & Cardiovascular Systems
(149)
Female
(141)
Male
(141)
Aged
(128)
Middle Aged
(115)
Biological And Medical Sciences
(90)
Medical Sciences
(90)
Cardiology. Vascular System
(79)
Treatment Outcome
(77)
Heart
(70)
Medicine
(62)
Coronary Heart Disease
(61)
Heart Attacks
(61)
Risk Factors
(60)
Acute Coronary Syndromes
(59)
Myocardial Infarction
(58)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation

Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome

Mo1999 How Often Does Major Gastrointestinal Bleeding in Patients Receiving Warfarin or Dabigatran Uncover Cancer? The U.S. Experience From the RELY Trial

Recommendations for the structure, organization, and operation of intensive cardiac care units

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Cardiovascular disease on a global scale: defining the path forward for research and practice

Third Universal Definition of Myocardial Infarction

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

Abstract 10162: NT-proBNP is Associated with Stroke, Heart Failure Hospitalizations, and Death in Patients with Atrial Fibrillation Without Oral Anticoagulation Regardless of Heart Rhythm

Abstract 12361: Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AF

Universal definition of myocardial infarction

Abstract 9290: Relationship Between Body Weight and Pharmacokinetics of Apixaban in Patients With Atrial Fibrillation: Insights from the ARISTOTLE Trial

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials

Third universal definition of myocardial infarction

Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy

High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin

NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization

Abstract 13812: A Functional Polymorphism in Matriptase-2, Rs855791, Modifies Interleukin-6 Mediated Cardiovascular Risk

Abstract 14397: Novel CYP2C19 Genetic Variants Associated With Stent Thrombosis - A Next Generation Sequencing Study

Suchergebnisse filtern